Hans Melander

1.1k total citations
17 papers, 729 citations indexed

About

Hans Melander is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Hans Melander has authored 17 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pediatrics, Perinatology and Child Health, 3 papers in Psychiatry and Mental health and 2 papers in Pharmacology. Recurrent topics in Hans Melander's work include Neonatal and fetal brain pathology (2 papers), Pharmaceutical industry and healthcare (2 papers) and Epilepsy research and treatment (2 papers). Hans Melander is often cited by papers focused on Neonatal and fetal brain pathology (2 papers), Pharmaceutical industry and healthcare (2 papers) and Epilepsy research and treatment (2 papers). Hans Melander collaborates with scholars based in Sweden, Netherlands and Denmark. Hans Melander's co-authors include Gunnar Ekbohm, Éric Abadie, Barbara van Zwieten‐Boot, Tomas Salmonson, Elisabeth Hultcrantz, H Svanholm, Karin Schenck‐Gustafsson, Lennart Bergfeldt, Anders Rane and A. Wigertz and has published in prestigious journals such as Journal of the American College of Cardiology, Biometrics and Epilepsia.

In The Last Decade

Hans Melander

17 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Melander Sweden 8 184 160 150 145 132 17 729
Salima Punja Canada 13 94 0.5× 70 0.4× 165 1.1× 17 0.1× 37 0.3× 27 543
M Kerekeş Germany 3 79 0.4× 102 0.6× 49 0.3× 50 0.3× 76 0.6× 6 337
Robert Harland United Kingdom 7 35 0.2× 99 0.6× 133 0.9× 56 0.4× 78 0.6× 17 688
B. Thornley United Kingdom 6 115 0.6× 92 0.6× 231 1.5× 15 0.1× 45 0.3× 9 451
Joanna Le Noury United Kingdom 12 47 0.3× 46 0.3× 213 1.4× 31 0.2× 86 0.7× 22 510
Mandy Kromp Germany 5 64 0.3× 77 0.5× 59 0.4× 36 0.2× 102 0.8× 6 355
G. Frank Liu United States 14 95 0.5× 43 0.3× 67 0.4× 19 0.1× 70 0.5× 43 925
Cindy Hwang United States 6 71 0.4× 34 0.2× 146 1.0× 113 0.8× 39 0.3× 8 405
Steve Palmer United Kingdom 9 190 1.0× 33 0.2× 446 3.0× 12 0.1× 33 0.3× 12 819
Stephen G. Bryant United States 16 31 0.2× 19 0.1× 164 1.1× 52 0.4× 117 0.9× 36 582

Countries citing papers authored by Hans Melander

Since Specialization
Citations

This map shows the geographic impact of Hans Melander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Melander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Melander more than expected).

Fields of papers citing papers by Hans Melander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Melander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Melander. The network helps show where Hans Melander may publish in the future.

Co-authorship network of co-authors of Hans Melander

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Melander. A scholar is included among the top collaborators of Hans Melander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Melander. Hans Melander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Melander, Hans. (2009). [Meta-analyses uncertain basis for first choice antidepressive agents].. PubMed. 106(14). 1030–1. 1 indexed citations
2.
Melander, Hans, Tomas Salmonson, Éric Abadie, & Barbara van Zwieten‐Boot. (2008). A regulatory Apologia — A review of placebo-controlled studies in regulatory submissions of new-generation antidepressants. European Neuropsychopharmacology. 18(9). 623–627. 86 indexed citations
3.
Melander, Hans, et al.. (2008). new drug applications pharmaceutical industry: review of studies in reporting from studies sponsored by Evidence b(i)ased medicine—selective. 2 indexed citations
4.
Hedenmalm, Karin, Hans Melander, & Gunnar Alván. (2007). The conscientious judgement of a DSMB – statistical stopping rules re-examined. European Journal of Clinical Pharmacology. 64(1). 69–72. 2 indexed citations
5.
Melander, Hans. (2005). [Selective reporting--greater problem than selective publishing?].. PubMed. 102(4). 224–5. 1 indexed citations
6.
7.
Beermann, B, et al.. (2001). Incorrect use and limited weight reduction of orlistat (Xenical) in clinical practice. European Journal of Clinical Pharmacology. 57(4). 309–311. 8 indexed citations
8.
Andersson, Lina, et al.. (2000). [How to reduce the problem of increasing sick-listing?].. PubMed. 97(13). 1576–8. 2 indexed citations
9.
Melander, Hans, et al.. (1999). [Why do we have increasing sick-listing?].. PubMed. 96(39). 4160–2. 1 indexed citations
10.
11.
Gerstoft, Jan, Hans Melander, Johan N. Bruun, et al.. (1997). Alternating Treatment with Didanosine and Zidovudine versus Either Drug Alone for the Treatment of Advanced HIV Infection. The Alter Study. Scandinavian Journal of Infectious Diseases. 29(2). 121–128. 4 indexed citations
12.
13.
Hultcrantz, Elisabeth, et al.. (1992). Body growth in relation to tonsillar enlargement and tonsillectomy. International Journal of Pediatric Otorhinolaryngology. 24(1). 55–61. 56 indexed citations
14.
Bergfeldt, Lennart, Hans Melander, & Karin Schenck‐Gustafsson. (1991). Time-dependent variation in the cardiac conduction system assessed in young healthy individuals at weeks' interval: Implications for clinical trials. Journal of the American College of Cardiology. 18(3). 792–800. 21 indexed citations
15.
Ekbohm, Gunnar & Hans Melander. (1989). The Subject-by-Formulation Interaction as a Criterion of Interchangeability of Drugs. Biometrics. 45(4). 1249–1249. 50 indexed citations
16.
Fabián, Pavel, et al.. (1986). [Effects and adverse effects of decongestants in otosalpingitis].. PubMed. 83(42). 3508–13. 2 indexed citations
17.
Melander, Hans, et al.. (1979). Production Functions and Factor Demand Functions in Postwar Swedish Industry. Scandinavian Journal of Economics. 81(4). 534–534. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salima Punja Breakdown of academic impact, for papers by M Kerekeş Breakdown of academic impact, for papers by Robert Harland Breakdown of academic impact, for papers by B. Thornley Breakdown of academic impact, for papers by Joanna Le Noury Breakdown of academic impact, for papers by Mandy Kromp Breakdown of academic impact, for papers by G. Frank Liu Breakdown of academic impact, for papers by Cindy Hwang Breakdown of academic impact, for papers by Steve Palmer Breakdown of academic impact, for papers by Stephen G. Bryant
Rankless by CCL
2026